Skip to main content
Medical information Clinical review pending

Gastroenterology Testing

FIB4 Index Test

The FIB4 Index Test is a non-invasive blood test that helps assess liver health and estimate the level of liver fibrosis. It measures specific biomarkers to provide insights into liver function.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (serum).
Results
Confirm with the laboratory before booking.
Preparation
No special preparation is required. Confirm with the laboratory before booking.
Test priceKSh 936

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the FIB4 Index Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Assessment of liver fibrosis in patients with chronic hepatitis B or C.
  • ✓Evaluation of liver health in individuals with risk factors like obesity, diabetes, or excessive alcohol consumption.
  • ✓Monitoring liver disease progression.
  • ✓Patients presenting with symptoms suggestive of liver disease.
  • ✓Risk stratification for liver-related complications.
02

In plain language

What this test helps you understand

The FIB4 Index Test is used to non-invasively estimate the degree of liver fibrosis in patients with chronic liver disease, helping to guide clinical management and potentially avoid the need for liver biopsy.
The FIB4 Index Test is a diagnostic tool used to evaluate liver health by estimating the level of fibrosis (scarring) in the liver. This non-invasive blood test is important for early detection and management of liver diseases, especially for individuals at risk. Understanding liver health is essential for overall well-being.

The test measures three key components: AST (SGOT), ALT (SGPT), and platelet count. These results are combined using a specific formula to calculate the FIB4 score, which estimates the degree of liver fibrosis.

This test is recommended for individuals who have symptoms of liver disease, are at risk due to factors like chronic hepatitis, obesity, diabetes, or excessive alcohol intake, or wish to monitor their liver health regularly.

Benefits of the FIB4 Index Test include being non-invasive, providing critical information about liver health without needing a biopsy, and aiding in the early detection of liver fibrosis for timely intervention.

Results provide an estimate of liver fibrosis. A higher score may indicate more advanced fibrosis, while a lower score suggests healthier liver function. It is crucial to discuss your results with a healthcare provider to understand their implications and determine appropriate next steps.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is required. Confirm with the laboratory before booking.
SampleBlood sample (serum).
MethodologyCalculation based on serum levels of AST, ALT, and platelet count.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
The FIB4 score is an estimate and may not be accurate in all individuals. Factors like certain medications or other medical conditions can influence the results. It is not a substitute for clinical evaluation or liver biopsy when indicated. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

The test measures levels of AST, ALT, and platelets in your blood to calculate a score that estimates the amount of scarring (fibrosis) in your liver.
No, it is a non-invasive blood test.
Individuals with risk factors for liver disease (like chronic hepatitis, obesity, diabetes, heavy alcohol use) or those showing symptoms of liver problems should consider this test.
A higher FIB4 score suggests a higher likelihood of significant liver fibrosis. Your doctor will interpret the results in the context of your overall health.
No, the FIB4 test is an estimate. A liver biopsy is still considered the gold standard for diagnosing liver fibrosis but is more invasive.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp